 |
|
Use of a Standardized Heparin Nomogram to Achieve Therapeutic Anticoagulation After Thrombolytic Therapy in Myocardial Infarction
Greg C. Flaker, MD;
John Bartolozzi, MD;
Vicki Davis, DrPH;
Carolyn McCabe;
Christopher P. Cannon, MD
Arch Intern Med. 1994;154(13):1492-1496.
Abstract
| |
Background
The recently completed Thrombolysis in Myocardial Infarction (TIMI) 4 Study compared three thrombolytic treatment regimens for acute myocardial infarction. The treatment arms included frontloaded recombinant tissue plasminogen activator (rtPA), anistreplase (APSAC), or both, in conjunction with an intravenous bolus of 5000 U of heparin, followed by 1000 U/h. To facilitate anticoagulation, a heparin nomogram was developed to maintain the therapeutic activated partial thromboplastin time at 1 1/2 to 2 times the control value.
Methods
A poll revealed that nine centers made use of the recommended heparin nomogram and six did not, adjusting the heparin dosage according to local practice. Anticoagulation parameters, major hemorrhagic events, and the frequency of heparin interruption were compared between centers that used and did not use the nomogram.
Results
Subtherapeutic activated partial thromboplastin time values were noted in 4%, 14%, 29%, 46%, 37%, and 34% of patients 8, 12, 24, 48, 72, and 96 hours, respectively, after heparin treatment was begun. Patients with subtherapeutic values at 24 hours were younger (mean±SD, 55.2±10.6 vs 59.6±10.6 years, P=.02) and weighed more (86.4±13.5 vs 78.9±15.7 kg, P=.007) than patients with therapeutic values. Centers that used the nomogram had significantly fewer subtherapeutic values at 48 and 96 hours. In addition, heparin therapy was interrupted less frequently at centers that used the nomogram (38.1% vs 68.7%, P<.001). Major spontaneous hemorrhage, reinfarction, and reocclusion rates were low and were about the same in the two groups.
Conclusions
The use of a heparin nomogram provided improved anticoagulation in patients treated with thrombolytic therapy for myocardial infarction. Weight- and age-adjusted heparin dosing may provide further improvement in anticoagulation with heparin therapy. Our findings support the need for frequent monitoring of the activated partial thromboplastin time and for a standardized approach to adjusting the heparin dosage.
(Arch Intern Med. 1994;154:1492-1496)
Author Affiliations
From the Division of Cardiology, Department of Medicine, University of Missouri-Columbia (Drs Flaker and Bartolozzi); Research Triangle Institute, Research Triangle Park, NC (Dr Davis); and the Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, Mass (Ms McCabe and Dr Cannon). A complete list of the Thrombolysis in Myocardial Infarction (TIMI) 4 Study investigators appears at the end of this report.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Predictors of Initial Nontherapeutic Anticoagulation With Unfractionated Heparin in ST-Segment Elevation Myocardial Infarction
Cheng et al.
Circulation 2009;119:1195-1202.
ABSTRACT
| FULL TEXT
Challenges to the Effective Use of Unfractionated Heparin in the Hospitalized Management of Acute Thrombosis
Hylek et al.
Arch Intern Med 2003;163:621-627.
ABSTRACT
| FULL TEXT
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
Hirsh et al.
Chest 2001;119
:64S-94S.
FULL TEXT
Automated Heparin-Delivery System to Control Activated Partial Thromboplastin Time : Evaluation in Normal Volunteers
Cannon et al.
Circulation 1999;99:751-756.
ABSTRACT
| FULL TEXT
Activated Partial Thromboplastin Time vs Heparin Concentration
Mungall et al.
Arch Intern Med 1998;158:1273-1275.
FULL TEXT
The Effectiveness of Implementing the Weight-Based Heparin Nomogram as a Practice Guideline
Raschke et al.
Arch Intern Med 1996;156:1645-1649.
ABSTRACT
State-of-the-Art Review : Monitoring of High-Dose Intravenous Heparin Therapy A Contribution to the Safety of Heparin Monitoring
Haushofer et al.
CLIN APPL THROMB HEMOST 1996;2:177-184.
ABSTRACT
The Successful Application of a Heparin Nomogram in a Community Hospital
Hollingsworth et al.
Arch Intern Med 1995;155:2095-2100.
ABSTRACT
|
